The new standard for osteoporosis fracture risk assessment
There is no doubt that DXA bone densitometry has a significant impact on the diagnosis of osteoporosis. Still, challenges remain in finding ways to balance the clinical and economic utility of the bone densitometers.
Moreover, while the measurement of BMD is important in the diagnosis of osteoporosis, it has its own limitations. BMD alone cannot identify all patients who are at high risk of bone fracture.
TBS Osteo is the missing link to bone fracture risk prediction and to boost your DXA business
TBS Osteo is an advanced imaging software powered by TBS iNsight (medical AI technology) application for bone densitometers assessing the microarchitectural deterioration of bone tissue.
It computes a Trabecular Bone Score (TBS), which provides extremely useful additional clinical information as to the microarchitecture of the bone. TBS Osteo helps capture an additional 30% of patients at fracture risk.*
*The Manitoba Study: Prospective study that aimed to elucidate the ability of lumbar spine TBS to predict future clinical osteoporotic fractures. Sample: 29,407 women age 50 or older at time of baseline in the Canadian province of Manitoba, mean follow-up time of 4.7 years. Hans et al. ,2011, J. Bone Miner. Res. 26
TBS Osteo is a clinical, operational and financial added value
US Reimbursement code for TBS available for use since January 2022
Get supporting evidence for payer coverage of Trabecular Bone Score (TBS) by downloading our Payer Dossier here: